Price and affordability of direct-acting antiviral regimens for hepatitis C virus in the United States

Lignende værker

• The Current Status of US and Global Access to Direct‐Acting Antiviral Regimens for Hepatitis C Virus Infection
  af: Graham, Camilla S.
  Udgivet: (2020)
• Minimum target prices for production of direct-acting antivirals and associated diagnostics to combat hepatitis C virus
  af: van de Ven, Nikolien, et al.
  Udgivet: (2015)
• Hepatitis C Retreatment in the Era of Direct-Acting Antivirals: Projections in the United States
  af: Chhatwal, Jagpreet, et al.
  Udgivet: (2018)
• Direct-Acting Antivirals and Hepatitis C: The Ethics of Price and Rationing by Genotype
  af: Walker, Alexis, et al.
  Udgivet: (2018)
• Clinical Laboratory Testing in the Era of Directly Acting Antiviral Therapies for Hepatitis C
  af: Wilson, Eleanor M., et al.
  Udgivet: (2016)